Chih‐Chia Yu
Impact in
-
- Beetle Biology and Toxicology Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Cell death mechanisms and regulation 2
- RNA modifications and cancer 2
-
- NF-κB Signaling Pathways 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Hui‐Fen Liao (7 shared papers)Shih‐Kai Hung (16 shared papers)Yu‐Chieh Su (9 shared papers)Hon‐Yi Lin (13 shared papers)Hsu-Chueh Ho (5 shared papers)Yu-Jen Chen (2 shared papers)Wen‐Yen Chiou (10 shared papers)Hsien‐Bin Huang (4 shared papers)
- Journals
- PLoS ONE (2 papers)Cancers (2 papers)Journal of Clinical Oncology (1 paper)PROTEOMICS - CLINICAL APPLICATIONS (1 paper)Cancer Cell International (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chih‐Chia Yu
22 papers receiving 353 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 110
- Oncology 82
- Molecular Biology 161
- Complementary and alternative medicine 17
- Otorhinolaryngology 7
Countries citing papers authored by Chih‐Chia Yu
This map shows the geographic impact of Chih‐Chia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Chia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Chia Yu more than expected).
Fields of papers citing papers by Chih‐Chia Yu
This network shows the impact of papers produced by Chih‐Chia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Chia Yu. The network helps show where Chih‐Chia Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chih‐Chia Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 72 | |
| 2 | 2008 | 57 | |
| 3 | 2009 | 30 | |
| 4 | 2006 | 29 | |
| 5 | 2016 | 25 | |
| 6 | RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint. | 2014 | 24 |
| 7 | 2018 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2019 | 14 | |
| 10 | 2010 | 12 | |
| 11 | 2014 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2012 | 8 | |
| 15 | 2023 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2009 | 2 |
About Chih‐Chia Yu
Chih‐Chia Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 22 papers that have together received 354 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Cell death mechanisms and regulation (2 papers), NF-κB Signaling Pathways (2 papers), Effects of Radiation Exposure (2 papers), Immune Response and Inflammation (2 papers), RNA modifications and cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (110 citations), Oncology (82 citations), Molecular Biology (161 citations), Complementary and alternative medicine (17 citations) and Otorhinolaryngology (7 citations). Chih‐Chia Yu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Hui‐Fen Liao, Shih‐Kai Hung, Yu‐Chieh Su, Hon‐Yi Lin, Hsu-Chueh Ho, Yu-Jen Chen, Wen‐Yen Chiou, Hsien‐Bin Huang, Moon‐Sing Lee and Guangsheng Wang. Their work appears in journals such as PLoS ONE, Cancers, Journal of Clinical Oncology, PROTEOMICS - CLINICAL APPLICATIONS and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.